Rare diseases
Investigational molecules
Locations
459 conditions with trials, the busiest first
1 397 trials across Europe, recruiting first
Study on the Effectiveness and Safety of Oxymetazoline Hydrochloride Eye Drops for Adults with Acquired Blepharoptosis
BulgariaStudy on the Long-term Safety of TAK-861 for Patients with Narcolepsy Type 1
AustriaStudy on the Effectiveness of Etanercept and Methotrexate for Patients with Giant Cell Arteritis
PolandStudy on the Safety and Effectiveness of Dazucorilant for Patients with Amyotrophic Lateral Sclerosis (ALS)
BelgiumA Study of ANX005 for Patients Recently Diagnosed with Guillain-Barré Syndrome to Evaluate How the Drug Works in the Body and Its Safety
DenmarkA Phase 3 Randomized, Double-blind,Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants with Obstructive Sleep Apnea not on Positive Airway Pressure Therapy and Living with Overweight or Obesity (MARITIME-OSA-2)
CzechiaA Phase 2 Study of MZE782 Safety, Tolerability, and Efficacy in Adults with Phenylketonuria
FranceNon‑inferiority of fractional varicella zoster virus glycoprotein E vaccine (AS01B) versus recombinant varicella zoster virus glycoprotein E vaccine in adults with shingles
The NetherlandsEfficacy, Safety, and Tolerability of NBI-1065890 in Adults with Tardive Dyskinesia
BulgariaA study of SAR448851 with florquinitau (18F) to assess safety and effectiveness in early Alzheimer’s disease
GermanyPhase 2 Study Evaluating OV329 on Photo‑Induced EEG Response in Adults with Epilepsy
The NetherlandsPhase 2 Randomized Study of Mivelsiran in Adults with Early-Stage Down Syndrome-Associated Alzheimer’s Disease
GermanyThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
